The R & D and manufacturing platform for contact lenses, "Ares", has completed over 100 million RMB in Series B+ financing.

36Kr learned that recently, "Ares", a R & D and manufacturing platform for contact lenses, announced the completion of over 100 million RMB in Series B+ financing. This round of financing was exclusively led by Qianji Capital, and EC Capital served as the exclusive financial advisor for this round of financing.